Amylin Pharmaceuticals to Webcast Year-End Results
January 23 2007 - 4:05PM
PR Newswire (US)
SAN DIEGO, Jan. 23 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Quarterly
Update Conference Call for the fourth quarter and full year 2006 on
Tuesday, January 30, 2007 at 5:00 p.m. ET/2:00 p.m. PT. Ginger L.
Graham, Amylin's Chief Executive Officer, will lead the call. On
the same date, at the close of market, Amylin will release
financial results for the fourth quarter and year ended December
31, 2006. The call will be webcast live through Amylin's corporate
website and a recording will be made available following the close
of the call. To access the webcast, please log on to
http://www.amylin.com/ approximately fifteen minutes prior to the
call to register, download and install any necessary audio
software. For those without access to the Internet, the live call
may be accessed by phone by calling (866) 362-4820 (domestic) or
(617) 597-5345 (international), passcode 66497284. A replay of the
call will also be available by phone for 24 hours beginning
approximately one hour after the close of the call and can be
accessed at (888) 286-8010 (domestic) or (617) 801-6888
(international), passcode 65801712. About Amylin Amylin
Pharmaceuticals is a biopharmaceutical company committed to
improving lives through the discovery, development and
commercialization of innovative medicines. Amylin has developed and
gained approval for two first- in-class medicines for diabetes,
SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)
injection. Amylin's research and development activities leverage
the company's expertise in metabolism to develop promising
therapies to treat diabetes and obesity. Amylin is located in San
Diego, California with over 1500 employees nationwide. Further
information on Amylin Pharmaceuticals and its pipeline in
metabolism is available at http://www.amylin.com/. DATASOURCE:
Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive
Director, Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024